The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics ...

NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders and Kadimastem Ltd. ("Kadimastem"), a clinical-stage ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

The global regenerative medicine market is poised for remarkable expansion, expected to record a compound annual growth rate (CAGR) of around 17% during the forecast period. This surge is primarily ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses.

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

Lateone monsoon evening in Tiruppur, a textile buyer ran two fingers across a swatch he couldn’t quite place. It felt like ...

The world is changing fast, and some pretty wild ideas are starting to look like they’ll actually happen. We’re talking about ...

The scientist responsible for creating the world’s first “genetically modified” babies has just been sentenced to three years ...

Scientists are venturing into the realm of de-extinction, aiming to revive the woolly mammoth using advanced genetic ...

As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...